Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15075540rdf:typepubmed:Citationlld:pubmed
pubmed-article:15075540lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:15075540lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:15075540lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:15075540lifeskim:mentionsumls-concept:C0040077lld:lifeskim
pubmed-article:15075540lifeskim:mentionsumls-concept:C0231174lld:lifeskim
pubmed-article:15075540lifeskim:mentionsumls-concept:C0887947lld:lifeskim
pubmed-article:15075540pubmed:issue2lld:pubmed
pubmed-article:15075540pubmed:dateCreated2004-4-12lld:pubmed
pubmed-article:15075540pubmed:abstractTextTo investigate the impact of 215 HIV-1 revertants on the risk of virological failure of the first thymidine analog-containing highly active antiretroviral therapy (HAART).lld:pubmed
pubmed-article:15075540pubmed:languageenglld:pubmed
pubmed-article:15075540pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15075540pubmed:citationSubsetIMlld:pubmed
pubmed-article:15075540pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15075540pubmed:statusMEDLINElld:pubmed
pubmed-article:15075540pubmed:monthJanlld:pubmed
pubmed-article:15075540pubmed:issn0269-9370lld:pubmed
pubmed-article:15075540pubmed:authorpubmed-author:BerrierJJlld:pubmed
pubmed-article:15075540pubmed:authorpubmed-author:d'Arminio...lld:pubmed
pubmed-article:15075540pubmed:authorpubmed-author:MoroniMauroMlld:pubmed
pubmed-article:15075540pubmed:authorpubmed-author:ChiodoFrances...lld:pubmed
pubmed-article:15075540pubmed:authorpubmed-author:GhinelliFlori...lld:pubmed
pubmed-article:15075540pubmed:authorpubmed-author:Cozzi-LepriAl...lld:pubmed
pubmed-article:15075540pubmed:authorpubmed-author:PernoCarlo...lld:pubmed
pubmed-article:15075540pubmed:authorpubmed-author:BalottaClaudi...lld:pubmed
pubmed-article:15075540pubmed:authorpubmed-author:ViolinMichela...lld:pubmed
pubmed-article:15075540pubmed:authorpubmed-author:VellecaRossel...lld:pubmed
pubmed-article:15075540pubmed:authorpubmed-author:VincentiAnton...lld:pubmed
pubmed-article:15075540pubmed:authorpubmed-author:D'EliaSalvato...lld:pubmed
pubmed-article:15075540pubmed:issnTypePrintlld:pubmed
pubmed-article:15075540pubmed:day23lld:pubmed
pubmed-article:15075540pubmed:volume18lld:pubmed
pubmed-article:15075540pubmed:ownerNLMlld:pubmed
pubmed-article:15075540pubmed:authorsCompleteYlld:pubmed
pubmed-article:15075540pubmed:pagination227-35lld:pubmed
pubmed-article:15075540pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15075540pubmed:meshHeadingpubmed-meshheading:15075540...lld:pubmed
pubmed-article:15075540pubmed:meshHeadingpubmed-meshheading:15075540...lld:pubmed
pubmed-article:15075540pubmed:meshHeadingpubmed-meshheading:15075540...lld:pubmed
pubmed-article:15075540pubmed:meshHeadingpubmed-meshheading:15075540...lld:pubmed
pubmed-article:15075540pubmed:meshHeadingpubmed-meshheading:15075540...lld:pubmed
pubmed-article:15075540pubmed:meshHeadingpubmed-meshheading:15075540...lld:pubmed
pubmed-article:15075540pubmed:meshHeadingpubmed-meshheading:15075540...lld:pubmed
pubmed-article:15075540pubmed:meshHeadingpubmed-meshheading:15075540...lld:pubmed
pubmed-article:15075540pubmed:meshHeadingpubmed-meshheading:15075540...lld:pubmed
pubmed-article:15075540pubmed:meshHeadingpubmed-meshheading:15075540...lld:pubmed
pubmed-article:15075540pubmed:meshHeadingpubmed-meshheading:15075540...lld:pubmed
pubmed-article:15075540pubmed:meshHeadingpubmed-meshheading:15075540...lld:pubmed
pubmed-article:15075540pubmed:meshHeadingpubmed-meshheading:15075540...lld:pubmed
pubmed-article:15075540pubmed:meshHeadingpubmed-meshheading:15075540...lld:pubmed
pubmed-article:15075540pubmed:meshHeadingpubmed-meshheading:15075540...lld:pubmed
pubmed-article:15075540pubmed:meshHeadingpubmed-meshheading:15075540...lld:pubmed
pubmed-article:15075540pubmed:meshHeadingpubmed-meshheading:15075540...lld:pubmed
pubmed-article:15075540pubmed:meshHeadingpubmed-meshheading:15075540...lld:pubmed
pubmed-article:15075540pubmed:year2004lld:pubmed
pubmed-article:15075540pubmed:articleTitleRisk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy.lld:pubmed
pubmed-article:15075540pubmed:affiliationInstitute of Infectious and Tropical Diseases, University of Milan, Italy.lld:pubmed
pubmed-article:15075540pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15075540pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:15075540pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15075540lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15075540lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15075540lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15075540lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15075540lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15075540lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15075540lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15075540lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15075540lld:pubmed